In a competing risk analysis, the associations of recurrent stroke and cardiovascular events (excluding vascular death) with increased SDF-1 levels in patients with diabetes mellitus at one year were still significant treating death as a competing risk (Supplementary Table 4). This evidence concerns the gene CXCL12 and diabetes mellitus.